OvaScience Inc (OVAS.OQ)
OVAS.OQ on NASDAQ Stock Exchange Global Market
0.87USD
20 Apr 2018
0.87USD
20 Apr 2018
Change (% chg)
$0.00 (+0.25%)
$0.00 (+0.25%)
Prev Close
$0.87
$0.87
Open
$0.86
$0.86
Day's High
$0.88
$0.88
Day's Low
$0.86
$0.86
Volume
7,770
7,770
Avg. Vol
90,354
90,354
52-wk High
$1.96
$1.96
52-wk Low
$0.71
$0.71
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 0.09 | -0.239 |
| Sep '17 | 0.06 | -0.262 | |
| Jun '17 | 0.08 | -0.510 | |
| Mar '17 | 0.06 | -0.418 | |
| FY 2016 | Dec '16 | 0.12 | -0.635 |
| Sep '16 | 0.20 | -0.542 | |
| Jun '16 | 0.19 | -0.618 | |
| Mar '16 | 0.15 | -0.797 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-18 | 3 | 2.06 | 5.52 | 0.30 | 5.27 |
| Year Ending Dec-19 | 2 | 11.29 | 21.25 | 1.33 | 15.66 |
| Earnings (per share) | |||||
| Year Ending Dec-18 | 3 | -1.16 | -1.08 | -1.33 | -1.23 |
| Year Ending Dec-19 | 2 | -1.08 | -0.92 | -1.24 | -0.58 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 84.02 | 32.74 | |
| P/E High - Last 5 Yrs. | -- | 293.18 | 45.72 | |
| P/E Low - Last 5 Yrs. | -- | 91.59 | 24.22 | |
| Beta | 3.53 | 0.90 | 0.88 | |
| Price to Sales (TTM) | 107.44 | 110.89 | 5.71 | |
| Price to Book (MRQ) | 0.62 | 13.58 | 5.37 | |
| Price to Tangible Book (MRQ) | 0.62 | 14.04 | 6.95 | |
| Price to Cash Flow (TTM) | -- | 71.40 | 23.32 | |
| % Owned Institutions | 61.07 | 12.75 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.31 | 1.50 | |
| Dividend Yield - 5 Year Avg | -- | 0.26 | 1.51 | |
| Dividend 5 Year Growth Rate | -- | 1.66 | 5.32 | |
| Payout Ratio(TTM) | -- | 15.72 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -55.56 | 399.08 | 9.21 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -17.99 | 78.82 | 5.69 | |
| Sales - 5 Yr. Growth Rate | -- | 32.16 | 10.32 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 17.51 | 25.00 | 19.36 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 25.53 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 38.99 | 10.76 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 40.29 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.80 | 2.19 |
| Current Ratio (MRQ) | 7.54 | 5.30 | 2.98 |
| LT Debt to Equity (MRQ) | 0.00 | 22.96 | 12.18 |
| Total Debt to Equity (MRQ) | 0.00 | 24.62 | 16.45 |
| Interest Coverage (TTM) | -88.09 | -99.35 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -660.22 | 40.02 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | -- | 51.13 | 52.20 | |
| EBITD Margin (TTM) | -13,513.98 | -- | -- | |
| EBITD - 5 Yr. Avg | -25,151.51 | -574.75 | 10.96 | |
| Operating Margin (TTM) | -15,881.51 | -718.53 | 4.73 | |
| Operating Margin - 5 Yr. Avg. | -26,194.30 | -596.06 | 6.40 | |
| Pre-Tax Margin (TTM) | -16,111.18 | -693.00 | 5.57 | |
| Pre-Tax Margin - 5 Yr. Avg. | -26,588.92 | -599.42 | 6.81 | |
| Net Profit Margin (TTM) | -16,132.26 | -694.22 | 1.87 | |
| Net Profit Margin - 5 Yr. Avg. | -26,618.60 | -602.27 | 3.09 | |
| Effective Tax Rate (TTM) | -- | 22.62 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.21 | 23.96 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 3,941 | 22,626,821 | 846,830,978 | |
| Net Income/Employee (TTM) | -635,720 | 2,971,371 | 99,616,195 | |
| Receivable Turnover (TTM) | -- | 20.16 | 5.78 | |
| Inventory Turnover (TTM) | -- | 2.37 | 3.35 | |
| Asset Turnover (TTM) | 0.00 | 0.39 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -59.39 | -1.11 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | -71.11 | -0.57 | 12.31 | |
| Return on Investment (TTM) | -65.22 | 1.58 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | -79.37 | 2.21 | 16.10 | |
| Return on Equity (TTM) | -65.89 | 2.41 | 16.07 | |
| Return on Equity - 5 Yr. Avg. | -80.50 | 3.09 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 135.74 | -- | -- |
| EPS (TTM) % | 5.35 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for OvaScience Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-AIGH Investment Partners Reports 6.2 Percent Passive Stake In Ovascience Inc As Of March 28, 2018
- BRIEF-BML Investment Partners Reports 6.4 Pct Passive Stake In Ovascience
- BRIEF-Ovascience Reports Q4 Loss Per Share $0.24
- BRIEF-OvaScience Says Provided Intrexon Corp With Written Notice Of Termination Of Exclusive Channel Collaboration Agreement, Dated Dec 18, 2013
- BRIEF-Ovascience Says Reducing Headcount By Approximately 50 Percent
Institutional Holders
| % Shares Owned: | 52.05% |
| # of Holders: | 77 |
| Total Shares Held: | 18,595,588 |
| 3 Mo. Net Change: | 976,955 |
| # New Positions: | 3 |
| # Closed Positions: | 0 |
| # Increased Positions: | 3 |
| # Reduced Positions: | 1 |
| # Net Buyers: | 2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.